A guanosine metabolism-bioenergetics intersection drives Parkinson’s disease

Verdict. We show here that the reliance on these two purine-based metabolites intersect at another PD susceptibility gene that encodes nucleoside diphosphate kinase (NDK) which converts ATP into GTP. It intersects mitochondrial stress/dysfunction themes (mitochondrial dysfunction; functional impairment; bioenergetics).

What the authors report

Several Parkinson’s Disease (PD) linked mutations are known to drive deficits in a pathway that relies on an adequate supply of guanosine nucleotide triphosphate (GTP) to drive cellular neuronal processes. Similarly, there is strong evidence that a deficit in bioenergetic support for neuron function is also a major genetic driver of PD.

Key results stated in the abstract include the following. We show here that the reliance on these two purine-based metabolites intersect at another PD susceptibility gene that encodes nucleoside diphosphate kinase (NDK) which converts ATP into GTP. We show that overexpression of NDK is strongly protective both in-vivo and in-vitro to metabolic lesions and identify mutations in NDK in humans associated both with increased risk and protection from PD. We discovered that NDK lies at the intersection of proper ATP production, de novo synthesis of guanosine diphosphate and the activity of GTP cyclohydrolase I, a consumptive pathway needed to produce the bioactive metabolite tetrahydrobiopterin (BH 4 ) required for mitochondrial function.

Why it matters for mitochondrial biology

Within mitochondrial research, this work maps primarily to metabolism, neurobiology. It is relevant to mitochondrial dysfunction discourse because the abstract invokes mitochondrial dysfunction, functional impairment, bioenergetics, disease context. That does not by itself establish a validated disease mechanism; it indicates thematic proximity. Causal language appears in the abstract; such claims should be treated as provisional until design details (loss-of-function, rescue, dose-response) are verified. Server: biorxiv. Posted 2026-08-04. Synthesis confidence is bounded by abstract completeness.

Study design (abstract-level)

The abstract does not cleanly separate methods from results. Treat design details as incomplete until the full preprint is inspected.

Principal findings

1. We show here that the reliance on these two purine-based metabolites intersect at another PD susceptibility gene that encodes nucleoside diphosphate kinase (NDK) which converts ATP into GTP.
2. We show that overexpression of NDK is strongly protective both in-vivo and in-vitro to metabolic lesions and identify mutations in NDK in humans associated both with increased risk and protection from PD.
3. We discovered that NDK lies at the intersection of proper ATP production, de novo synthesis of guanosine diphosphate and the activity of GTP cyclohydrolase I, a consumptive pathway needed to produce the bioactive metabolite tetrahydrobiopterin (BH 4 ) required for mitochondrial function.
4. Loss of NDK and impairment in guanosine nucleotide synthesis exacerbate synaptic dysfunction, while boosting the GTP consuming pathway promotes bioenergetics.
5. Additionally, analysis of genetic data taken from over 64,000 PD affected individuals and 38,000 controls from diverse ancestries reveal that several genes lying at the intersection of guanosine nucleotide metabolism and bioenergetics pose a significant risk burden for PD.

Limitations of this brief

• This Mitos brief is an abstract-level synthesis of a preprint; it is not peer review and not a substitute for reading the full paper.
• Preprint status: findings may change with revision or journal review.
• Effect sizes, n numbers, statistics, and full experimental controls are typically incomplete at abstract resolution.
• Primary source: biorxiv DOI 10.64898/2026.07.29.741503 (posted 2026-08-04).

Open scientific questions

• Which specific experimental panels in the full paper establish the strongest causal claim, and how robust are the controls?
• Is the mitochondrial phenotype cell-autonomous in neurons/glia, or secondary to systemic/inflammatory signals?
• How do these findings sit relative to prior literature on the same pathway—replication, contradiction, or incremental extension?

Bottom line

For mitochondrial biologists focused on metabolism, neurobiology, this preprint is worth full-text review soon. Abstract-level takeaway: We show here that the reliance on these two purine-based metabolites intersect at another PD susceptibility gene that encodes nucleoside diphosphate kinase (NDK) which converts ATP into GTP. Confirm methods, effect sizes, and controls in the full PDF before citing the result as established.

Bibliographic record

Abstract-based editorial synthesis by Mitos. Not peer review.